Mogrify
PrivateLast Round
Series A
Extension
Oct 2, 2023
Total Funding Raised
$77.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mogrify is a biotechnology company that develops proprietary platform technologies for direct cellular reprogramming to create a novel class of in vivo reprogramming therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mogrify Comparables
Compare Mogrify with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iReprogram, Inc. | 89% | |
| bit.bio | 78% | |
| GC Therapeutics | 77% |
Mogrify Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 2, 2023 | ||||
| Series A Extension | May 4, 2021 | ||||
| Grant | Jan 28, 2020 | ||||
| Series A | Oct 14, 2019 | ||||
| Seed | Feb 20, 2019 |
Key People
Founding team and executive leadership
Mogrify Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SBRI Healthcare | Grant |
| Innovate UK | Seed |
| Astellas Venture Management | Series A Extension, Series A |
| Ahren Innovation Capital | Series A Extension, Seed, Series A |
| Parkwalk Advisors | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 83% MoM.
- Jan 28, 2020
$1.1M grant received from SBRI Healthcare
Mogrify Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mogrify's valuation, stock price, and market status.
Is Mogrify a public or private company?
Mogrify is a private company.
What is the current stock price of Mogrify?
Mogrify is a private company with no public stock price. No recent secondary market data is available.
How much is Mogrify worth (valuation)?
Valuation information for Mogrify is not publicly available.
Can I buy Mogrify stock?
Mogrify shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mogrify's last funding round?
Mogrify's most recent funding round was Series A Extension on October 2, 2023.
Who are the main investors in Mogrify?
Key investors in Mogrify include Astellas Venture Management, Ahren Innovation Capital, Parkwalk Advisors.
Will Mogrify IPO soon?
No public IPO plans have been announced for Mogrify.
How can I track Mogrify secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mogrify's secondary market activity and sign up for updates.